Cargando…

Decreased expression of endogenous feline leukemia virus in cat lymphomas: a case control study

BACKGROUND: Cats infected with exogenous feline leukemia virus (exFeLV) have a higher chance of lymphoma development than uninfected cats. Furthermore, an increased exFeLV transcription has been detected in lymphomas compared to non-malignant tissues. The possible mechanisms of lymphoma development...

Descripción completa

Detalles Bibliográficos
Autores principales: Krunic, Milica, Ertl, Reinhard, Hagen, Benedikt, Sedlazeck, Fritz J, Hofmann-Lehmann, Regina, von Haeseler, Arndt, Klein, Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424575/
https://www.ncbi.nlm.nih.gov/pubmed/25879730
http://dx.doi.org/10.1186/s12917-015-0378-9
_version_ 1782370353730813952
author Krunic, Milica
Ertl, Reinhard
Hagen, Benedikt
Sedlazeck, Fritz J
Hofmann-Lehmann, Regina
von Haeseler, Arndt
Klein, Dieter
author_facet Krunic, Milica
Ertl, Reinhard
Hagen, Benedikt
Sedlazeck, Fritz J
Hofmann-Lehmann, Regina
von Haeseler, Arndt
Klein, Dieter
author_sort Krunic, Milica
collection PubMed
description BACKGROUND: Cats infected with exogenous feline leukemia virus (exFeLV) have a higher chance of lymphoma development than uninfected cats. Furthermore, an increased exFeLV transcription has been detected in lymphomas compared to non-malignant tissues. The possible mechanisms of lymphoma development by exFeLV are insertional mutagenesis or persistent stimulation of host immune cells by viral antigens, bringing them at risk for malignant transformation. Vaccination of cats against exFeLV has in recent years decreased the overall infection rate in most countries. Nevertheless, an increasing number of lymphomas have been diagnosed among exFeLV-negative cats. Endogenous feline leukemia virus (enFeLV) is another retrovirus for which transcription has been observed in cat lymphomas. EnFeLV provirus elements are present in the germline of various cat species and share a high sequence similarity with exFeLV but, due to mutations, are incapable of producing infectious viral particles. However, recombination between exFeLV and enFeLV could produce infectious particles. RESULTS: We examined the FeLV expression in cats that have developed malignant lymphomas and discussed the possible mechanisms that could have induced malignant transformation. For expression analysis we used next-generation RNA-sequencing (RNA-Seq) and for validation reverse transcription quantitative PCR (RT-qPCR). First, we showed that there was no expression of exFeLV in all samples, which eliminates the possibility of recombination between exFeLV and enFeLV. Next, we analyzed the difference in expression of three enFeLV genes between control and lymphoma samples. Our analysis showed an average of 3.40-fold decreased viral expression for the three genes in lymphoma compared to control samples. The results were confirmed by RT-qPCR. CONCLUSIONS: There is a decreased expression of enFeLV genes in lymphomas versus control samples, which contradicts previous observations for the exFeLV. Our results suggest that a persistent stimulation of host immune cells is not an appropriate mechanism responsible for malignant transformation caused by feline endogenous retroviruses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-015-0378-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4424575
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44245752015-05-09 Decreased expression of endogenous feline leukemia virus in cat lymphomas: a case control study Krunic, Milica Ertl, Reinhard Hagen, Benedikt Sedlazeck, Fritz J Hofmann-Lehmann, Regina von Haeseler, Arndt Klein, Dieter BMC Vet Res Research Article BACKGROUND: Cats infected with exogenous feline leukemia virus (exFeLV) have a higher chance of lymphoma development than uninfected cats. Furthermore, an increased exFeLV transcription has been detected in lymphomas compared to non-malignant tissues. The possible mechanisms of lymphoma development by exFeLV are insertional mutagenesis or persistent stimulation of host immune cells by viral antigens, bringing them at risk for malignant transformation. Vaccination of cats against exFeLV has in recent years decreased the overall infection rate in most countries. Nevertheless, an increasing number of lymphomas have been diagnosed among exFeLV-negative cats. Endogenous feline leukemia virus (enFeLV) is another retrovirus for which transcription has been observed in cat lymphomas. EnFeLV provirus elements are present in the germline of various cat species and share a high sequence similarity with exFeLV but, due to mutations, are incapable of producing infectious viral particles. However, recombination between exFeLV and enFeLV could produce infectious particles. RESULTS: We examined the FeLV expression in cats that have developed malignant lymphomas and discussed the possible mechanisms that could have induced malignant transformation. For expression analysis we used next-generation RNA-sequencing (RNA-Seq) and for validation reverse transcription quantitative PCR (RT-qPCR). First, we showed that there was no expression of exFeLV in all samples, which eliminates the possibility of recombination between exFeLV and enFeLV. Next, we analyzed the difference in expression of three enFeLV genes between control and lymphoma samples. Our analysis showed an average of 3.40-fold decreased viral expression for the three genes in lymphoma compared to control samples. The results were confirmed by RT-qPCR. CONCLUSIONS: There is a decreased expression of enFeLV genes in lymphomas versus control samples, which contradicts previous observations for the exFeLV. Our results suggest that a persistent stimulation of host immune cells is not an appropriate mechanism responsible for malignant transformation caused by feline endogenous retroviruses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12917-015-0378-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-04-10 /pmc/articles/PMC4424575/ /pubmed/25879730 http://dx.doi.org/10.1186/s12917-015-0378-9 Text en © Krunic et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Krunic, Milica
Ertl, Reinhard
Hagen, Benedikt
Sedlazeck, Fritz J
Hofmann-Lehmann, Regina
von Haeseler, Arndt
Klein, Dieter
Decreased expression of endogenous feline leukemia virus in cat lymphomas: a case control study
title Decreased expression of endogenous feline leukemia virus in cat lymphomas: a case control study
title_full Decreased expression of endogenous feline leukemia virus in cat lymphomas: a case control study
title_fullStr Decreased expression of endogenous feline leukemia virus in cat lymphomas: a case control study
title_full_unstemmed Decreased expression of endogenous feline leukemia virus in cat lymphomas: a case control study
title_short Decreased expression of endogenous feline leukemia virus in cat lymphomas: a case control study
title_sort decreased expression of endogenous feline leukemia virus in cat lymphomas: a case control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424575/
https://www.ncbi.nlm.nih.gov/pubmed/25879730
http://dx.doi.org/10.1186/s12917-015-0378-9
work_keys_str_mv AT krunicmilica decreasedexpressionofendogenousfelineleukemiavirusincatlymphomasacasecontrolstudy
AT ertlreinhard decreasedexpressionofendogenousfelineleukemiavirusincatlymphomasacasecontrolstudy
AT hagenbenedikt decreasedexpressionofendogenousfelineleukemiavirusincatlymphomasacasecontrolstudy
AT sedlazeckfritzj decreasedexpressionofendogenousfelineleukemiavirusincatlymphomasacasecontrolstudy
AT hofmannlehmannregina decreasedexpressionofendogenousfelineleukemiavirusincatlymphomasacasecontrolstudy
AT vonhaeselerarndt decreasedexpressionofendogenousfelineleukemiavirusincatlymphomasacasecontrolstudy
AT kleindieter decreasedexpressionofendogenousfelineleukemiavirusincatlymphomasacasecontrolstudy